• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘氨酸和 S-氯胺酮对 NMDA 受体的相反调节作用及对静息状态 EEG 伽马活动的影响:精神分裂症谷氨酸假说的新见解。

Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.

机构信息

Department of Psychiatry and Psychotherapy, Psychiatry Neuroimaging Branch (PNB), University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Center of Psychiatry, Justus-Liebig University, 35392 Giessen, Germany.

出版信息

Int J Mol Sci. 2023 Jan 18;24(3):1913. doi: 10.3390/ijms24031913.

DOI:10.3390/ijms24031913
PMID:36768234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916476/
Abstract

NMDA-receptor hypofunction is increasingly considered to be an important pathomechanism in schizophrenia. However, to date, it has not been possible to identify patients with relevant NMDA-receptor hypofunction who would respond to glutamatergic treatments. Preclinical models, such as the ketamine model, could help identify biomarkers related to NMDA-receptor function that respond to glutamatergic modulation, for example, via activation of the glycine-binding site. We, therefore, aimed to investigate the effects of opposing modulation of the NMDA receptor on gamma activity (30-100 Hz) at rest, the genesis of which appears to be highly dependent on NMDA receptors. The effects of subanesthetic doses of S-ketamine and pretreatment with glycine on gamma activity at rest were examined in twenty-five healthy male participants using 64-channel electroencephalography. Psychometric scores were assessed using the PANSS and the 5D-ASC. While S-ketamine significantly increased psychometric scores and gamma activity at the scalp and in the source space, pretreatment with glycine did not significantly attenuate any of these effects when controlled for multiple comparisons. Our results question whether increased gamma activity at rest constitutes a suitable biomarker for the target engagement of glutamatergic drugs in the preclinical ketamine model. They might further point to a differential role of NMDA receptors in gamma activity generation.

摘要

NMDA 受体功能低下被认为与精神分裂症的发病机制有关。然而,迄今为止,尚未能够识别出具有相关 NMDA 受体功能低下且对谷氨酸能治疗有反应的患者。临床前模型,如氯胺酮模型,可帮助确定与 NMDA 受体功能相关的生物标志物,这些标志物可通过激活甘氨酸结合位点来响应谷氨酸能调节。因此,我们旨在研究 NMDA 受体的相反调节对静息状态下γ活动(30-100 Hz)的影响,γ活动的产生似乎高度依赖于 NMDA 受体。使用 64 通道脑电图,我们在 25 名健康男性参与者中检查了亚麻醉剂量 S-氯胺酮和甘氨酸预处理对静息状态下γ活动的影响。使用 PANSS 和 5D-ASC 评估心理测量评分。S-氯胺酮显著增加了头皮和源空间的心理测量评分和γ活动,而在进行多次比较控制后,甘氨酸预处理并没有显著减弱这些影响。我们的结果质疑静息状态下增加的γ活动是否构成了临床前氯胺酮模型中谷氨酸能药物的靶标结合的合适生物标志物。它们可能进一步表明 NMDA 受体在γ活动产生中的作用不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/da2daf56a99d/ijms-24-01913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/f529408f0d8c/ijms-24-01913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/edc8e4f4b46d/ijms-24-01913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/bca36a833dbb/ijms-24-01913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/da2daf56a99d/ijms-24-01913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/f529408f0d8c/ijms-24-01913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/edc8e4f4b46d/ijms-24-01913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/bca36a833dbb/ijms-24-01913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bead/9916476/da2daf56a99d/ijms-24-01913-g004.jpg

相似文献

1
Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.甘氨酸和 S-氯胺酮对 NMDA 受体的相反调节作用及对静息状态 EEG 伽马活动的影响:精神分裂症谷氨酸假说的新见解。
Int J Mol Sci. 2023 Jan 18;24(3):1913. doi: 10.3390/ijms24031913.
2
Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia.甘氨酸可减轻精神分裂症氯胺酮模型中刺激诱发的γ振荡损伤。
Neuroimage. 2022 May 1;251:119004. doi: 10.1016/j.neuroimage.2022.119004. Epub 2022 Feb 14.
3
Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System.氯胺酮改变健康人类静息状态下的功能性γ和θ波连接:对靶向谷氨酸系统治疗精神分裂症的启示。
Front Psychiatry. 2021 Jun 10;12:671007. doi: 10.3389/fpsyt.2021.671007. eCollection 2021.
4
The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.代谢型谷氨酸受体变构调节在精神分裂症NMDA功能低下模型中的作用。
Georgian Med News. 2009 Dec(177):59-65.
5
Sarcosine (glycine transporter inhibitor) attenuates behavioural and biochemical changes induced by ketamine, in the rat model of schizophrenia.肌氨酸(甘氨酸转运体抑制剂)可减轻精神分裂症大鼠模型中由氯胺酮诱导的行为和生化变化。
Exp Brain Res. 2023 Feb;241(2):451-467. doi: 10.1007/s00221-022-06530-4. Epub 2022 Dec 28.
6
40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors.40赫兹听觉稳态反应是皮质N-甲基-D-天冬氨酸受体的药效学生物标志物。
Neuropsychopharmacology. 2016 Aug;41(9):2232-40. doi: 10.1038/npp.2016.17. Epub 2016 Feb 3.
7
The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans.氯胺酮和 D-环丝氨酸对人类高频静息 EEG 谱的影响。
Psychopharmacology (Berl). 2023 Jan;240(1):59-75. doi: 10.1007/s00213-022-06272-9. Epub 2022 Nov 19.
8
Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.亚麻醉剂量氯胺酮作用下听觉诱发γ 频段响应降低与类似精神分裂症的临床症状
Neuropsychopharmacology. 2019 Jun;44(7):1239-1246. doi: 10.1038/s41386-019-0328-5. Epub 2019 Feb 6.
9
Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.在 NMDA 受体阻断期间,健康受试者出现听觉言语幻觉与大脑两半球间γ 波段连接的改变有关。
Neuropsychopharmacology. 2018 Jun;43(7):1608-1615. doi: 10.1038/s41386-018-0014-z. Epub 2018 Feb 5.
10
[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].[精神分裂症的谷氨酸能假说:氯胺酮的临床研究]
Encephale. 2001 Jan-Feb;27(1):53-9.

引用本文的文献

1
Brain regulation training improves emotional competences in patients with alcohol use disorder.脑调节训练可改善酒精使用障碍患者的情绪能力。
Soc Cogn Affect Neurosci. 2024 Aug 1;19(1). doi: 10.1093/scan/nsae048.
2
EEG-vigilance regulation is associated with and predicts ketamine response in major depressive disorder.脑电图警觉调节与重度抑郁症中的氯胺酮反应相关并可预测该反应。
Transl Psychiatry. 2024 Jan 26;14(1):64. doi: 10.1038/s41398-024-02761-x.
3
The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial.

本文引用的文献

1
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.靶向 D-氨基酸氧化酶(DAAO)治疗精神分裂症:原理和研究现状。
CNS Drugs. 2022 Nov;36(11):1143-1153. doi: 10.1007/s40263-022-00959-5. Epub 2022 Oct 4.
2
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.基因组定位研究提示精神分裂症的发病与基因及突触生物学有关。
Nature. 2022 Apr;604(7906):502-508. doi: 10.1038/s41586-022-04434-5. Epub 2022 Apr 8.
3
Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia.
甲磺酸瑞马唑仑联合依托咪酯用于门诊结肠镜检查的有效性和安全性:一项前瞻性、随机、对照临床试验。
Drug Des Devel Ther. 2023 Sep 18;17:2875-2887. doi: 10.2147/DDDT.S425860. eCollection 2023.
甘氨酸可减轻精神分裂症氯胺酮模型中刺激诱发的γ振荡损伤。
Neuroimage. 2022 May 1;251:119004. doi: 10.1016/j.neuroimage.2022.119004. Epub 2022 Feb 14.
4
Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System.氯胺酮改变健康人类静息状态下的功能性γ和θ波连接:对靶向谷氨酸系统治疗精神分裂症的启示。
Front Psychiatry. 2021 Jun 10;12:671007. doi: 10.3389/fpsyt.2021.671007. eCollection 2021.
5
EPA guidance on treatment of negative symptoms in schizophrenia.美国环保署关于精神分裂症阴性症状治疗的指导意见。
Eur Psychiatry. 2021 Mar 17;64(1):e21. doi: 10.1192/j.eurpsy.2021.13.
6
Network Asynchrony Underlying Increased Broadband Gamma Power.网络异步导致宽带伽马功率增加。
J Neurosci. 2021 Mar 31;41(13):2944-2963. doi: 10.1523/JNEUROSCI.2250-20.2021. Epub 2021 Feb 16.
7
Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective.NMDA 受体拮抗剂能否在精神分裂症中重现自发性伽马波段活动模式?系统综述及展望。
Neurosci Biobehav Rev. 2021 May;124:308-323. doi: 10.1016/j.neubiorev.2021.02.005. Epub 2021 Feb 10.
8
Resting-state functional EEG connectivity in salience and default mode networks and their relationship to dissociative symptoms during NMDA receptor antagonism.静息态功能 EEG 连接在突显网络和默认模式网络及其与 NMDA 受体拮抗作用期间分离症状的关系。
Pharmacol Biochem Behav. 2021 Feb;201:173092. doi: 10.1016/j.pbb.2020.173092. Epub 2020 Dec 30.
9
Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.精神分裂症的新兴治疗靶点:精神病新型治疗策略的框架。
Expert Opin Ther Targets. 2021 Jan;25(1):15-26. doi: 10.1080/14728222.2021.1849144. Epub 2020 Nov 26.
10
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.谷氨酸能药物治疗精神分裂症的作用机制及靶点验证:在健康志愿者中进行的关于泊马谷氨酸和TS-134对氯胺酮诱发的精神病性症状及药物功能性磁共振成像的随机对照试验。
Neuropsychopharmacology. 2020 Oct;45(11):1842-1850. doi: 10.1038/s41386-020-0706-z. Epub 2020 May 13.